Christine T Mui
Examiner (ID: 2758, Phone: (571)270-3243 , Office: P/1797 )
Most Active Art Unit | 1797 |
Art Unit(s) | 1774, 1709, 1797, 1777 |
Total Applications | 1433 |
Issued Applications | 1052 |
Pending Applications | 84 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17557157
[patent_doc_number] => 11313852
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders
[patent_app_type] => utility
[patent_app_number] => 15/436919
[patent_app_country] => US
[patent_app_date] => 2017-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5528
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436919
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/436919 | Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders | Feb 19, 2017 | Issued |
Array
(
[id] => 11713598
[patent_doc_number] => 20170182097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'NON-HUMAN MAMMAL MODEL OF HUMAN DEGENERATIVE DISORDER, USES THEREOF, AND METHOD OF TREATING HUMAN DEGENERATIVE DISORDER'
[patent_app_type] => utility
[patent_app_number] => 15/429559
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18200
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429559 | Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder | Feb 9, 2017 | Issued |
Array
(
[id] => 11663591
[patent_doc_number] => 20170152310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'ANTIBODIES RECOGNIZING ALPHA-SYNUCLEIN'
[patent_app_type] => utility
[patent_app_number] => 15/429962
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18179
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429962
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429962 | Antibodies recognizing a-synuclein | Feb 9, 2017 | Issued |
Array
(
[id] => 12681925
[patent_doc_number] => 20180119141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => CRISPR/CAS GLOBAL REGULATOR SCREENING PLATFORM
[patent_app_type] => utility
[patent_app_number] => 15/411255
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411255
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/411255 | CRISPR/CAS GLOBAL REGULATOR SCREENING PLATFORM | Jan 19, 2017 | Abandoned |
Array
(
[id] => 12428319
[patent_doc_number] => 09975947
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Anti-alpha synuclein binding molecules
[patent_app_type] => utility
[patent_app_number] => 15/410128
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 31711
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15410128
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/410128 | Anti-alpha synuclein binding molecules | Jan 18, 2017 | Issued |
Array
(
[id] => 13837519
[patent_doc_number] => 20190022244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => BLOOD-BRAIN BARRIER VECTOR COMPOUNDS AND CONJUGATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/069602
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069602
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069602 | BLOOD-BRAIN BARRIER VECTOR COMPOUNDS AND CONJUGATES THEREOF | Jan 12, 2017 | Abandoned |
Array
(
[id] => 11590877
[patent_doc_number] => 20170115288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'METHOD FOR THE DIAGNOSIS OF NEUROMYELITIS OPTICA'
[patent_app_type] => utility
[patent_app_number] => 15/404293
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2911
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15404293
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/404293 | Method for the diagnosis of neuromyelitis optica | Jan 11, 2017 | Issued |
Array
(
[id] => 11569871
[patent_doc_number] => 20170108515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'ANTIBODIES TO DISULFATED HEPARIN DISACCHARIDE IN THE DIAGNOSIS OF NEUROPATHY'
[patent_app_type] => utility
[patent_app_number] => 15/391220
[patent_app_country] => US
[patent_app_date] => 2016-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7057
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15391220
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/391220 | ANTIBODIES TO DISULFATED HEPARIN DISACCHARIDE IN THE DIAGNOSIS OF NEUROPATHY | Dec 26, 2016 | Abandoned |
Array
(
[id] => 11937891
[patent_doc_number] => 20170242041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY'
[patent_app_type] => utility
[patent_app_number] => 15/391755
[patent_app_country] => US
[patent_app_date] => 2016-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 25926
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15391755
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/391755 | Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury | Dec 26, 2016 | Issued |
Array
(
[id] => 11757301
[patent_doc_number] => 20170204170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'ANTIBODY BASED REAGENT THAT SPECIFICALLY RECOGNIZES TOXIC OLIGOMERIC FORM OF BETA-AMYLOID'
[patent_app_type] => utility
[patent_app_number] => 15/390402
[patent_app_country] => US
[patent_app_date] => 2016-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13643
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15390402
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/390402 | ANTIBODY BASED REAGENT THAT SPECIFICALLY RECOGNIZES TOXIC OLIGOMERIC FORM OF BETA-AMYLOID | Dec 22, 2016 | Abandoned |
Array
(
[id] => 11529951
[patent_doc_number] => 20170089929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'Antibodies to TTR and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 15/373657
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14740
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15373657
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/373657 | Antibodies to TTR and Methods of Use | Dec 8, 2016 | Abandoned |
Array
(
[id] => 17526865
[patent_doc_number] => 11299537
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Methods for treatment of motor neuron diseases
[patent_app_type] => utility
[patent_app_number] => 16/060301
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 15028
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060301
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060301 | Methods for treatment of motor neuron diseases | Dec 5, 2016 | Issued |
Array
(
[id] => 11493729
[patent_doc_number] => 20170067913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'BIOMARKERS FOR PREDICTION, DIAGNOSIS, AND MONITORING OF ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/356484
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26068
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15356484
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/356484 | BIOMARKERS FOR PREDICTION, DIAGNOSIS, AND MONITORING OF ALZHEIMER'S DISEASE | Nov 17, 2016 | Abandoned |
Array
(
[id] => 13931903
[patent_doc_number] => 20190049467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => EXOSOMAL TAU AS A BIOMARKER FOR BRAIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/777168
[patent_app_country] => US
[patent_app_date] => 2016-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777168
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777168 | EXOSOMAL TAU AS A BIOMARKER FOR BRAIN DISORDERS | Nov 15, 2016 | Abandoned |
Array
(
[id] => 12227547
[patent_doc_number] => 09914781
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-03-13
[patent_title] => 'Binding agonist for treatment of neurological and other disorders'
[patent_app_type] => utility
[patent_app_number] => 15/351465
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 32093
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15351465
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/351465 | Binding agonist for treatment of neurological and other disorders | Nov 14, 2016 | Issued |
Array
(
[id] => 11555217
[patent_doc_number] => 20170101463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'BISPECIFIC ANTIBODY FRAGMENTS FOR NEUROLOGICAL DISEASE PROTEINS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/332954
[patent_app_country] => US
[patent_app_date] => 2016-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23976
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15332954
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/332954 | Bispecific antibody fragments for neurological disease proteins and methods of use | Oct 23, 2016 | Issued |
Array
(
[id] => 11950670
[patent_doc_number] => 20170254822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'METHODS AND KITS FOR DETECTING AND DIAGNOSING NEUROTRAUMA'
[patent_app_type] => utility
[patent_app_number] => 15/331880
[patent_app_country] => US
[patent_app_date] => 2016-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 42515
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15331880
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/331880 | METHODS AND KITS FOR DETECTING AND DIAGNOSING NEUROTRAUMA | Oct 22, 2016 | Abandoned |
Array
(
[id] => 13507831
[patent_doc_number] => 20180305458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/767843
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767843 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATORY DISEASES | Oct 13, 2016 | Abandoned |
Array
(
[id] => 11590899
[patent_doc_number] => 20170115311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'BACTERIOPHAGE GENE 3 PROTEIN COMPOSITIONS AND USE AS AMYLOID BINDING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/288237
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 26773
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288237
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/288237 | Bacteriophage gene 3 protein compositions and use as amyloid binding agents | Oct 6, 2016 | Issued |
Array
(
[id] => 13675203
[patent_doc_number] => 20160376335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => POLYMERS CONTAINING MULTIVALENT AMYLOID-BETA-BINDING D-PEPTIDES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 15/263728
[patent_app_country] => US
[patent_app_date] => 2016-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15263728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/263728 | POLYMERS CONTAINING MULTIVALENT AMYLOID-BETA-BINDING D-PEPTIDES AND THEIR USE | Sep 12, 2016 | Abandoned |